Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

TREM-1 Modulation Strategies for Sepsis

Frontiers in Immunology(2022)10.3389/fimmu.2022.907387Source: DataRank Database

TREM-1 Modulation Strategies for Sepsis is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 78 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access78 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 5.87)OA: goldTopics (33)Linked Datasets (18)DataCite Reuse (18)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Max Brenner ORCID,Ping Wang ORCID,Sara Siskind ORCID

Live enrichment

PubMed:35784361 PMC:PMC9240770 OpenAlex:https://openalex.org/W4282931802

NIGMS NIH HHS

Grant: R35 GM118337

NIAID NIH HHS

Grant: U01 AI035365

National Institutes of Health

Grant: 5R35GM118337-02

Novel Approaches to Maintaining Organ Function in Sepsis

National Institutes of Health

Grant: 2R01AI033655-05

ASYMMETRIC SYNTHESIS OF L-NUCLEOSIDES AS ANTI-HBV AGENTS

National Institutes of Health

FWCI

5.87

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.907387/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.907387/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.907387/full

journalhttps://doi.org/10.3389/fimmu.2022.907387

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35784361

Fields of Study

Inflammation biomarkers and pathways0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Triggering Receptor Expressed on Myeloid Cells-1HumansLigandsMembrane GlycoproteinsReceptors, ImmunologicSepsis

Keywords

SepsisImmune systemChemokineReceptorInflammationImmunologyDownregulation and upregulationMedicineCytokineMyeloidSeptic shockBiologyInternal medicineShockTrem-1DampMembrane GlycoproteinsRC581-607LigandsTriggering Receptor Expressed on Myeloid Cells-1HumansImmunologic diseases. AllergyReceptors, Immunologic

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 9 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.26696154.v1figshare

Additional file 9 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.26696154figshare

Additional file 5 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.26696142figshare

Additional file 6 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.26696145figshare

Additional file 7 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.26696148figshare

Additional file 5 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.26696142.v1figshare

Additional file 6 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.26696145.v1figshare

Additional file 8 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.26696151.v1figshare

Additional file 7 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.26696148.v1figshare

Additional file 8 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.26696151figshare

Additional file 3 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.26696136figshare

Additional file 2 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.25459648.v1figshare

Additional file 4 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.26696139.v1figshare

Additional file 4 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.26696139figshare

Additional file 1 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.25459480figshare

Additional file 1 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.25459480.v1figshare

Additional file 2 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.25459648figshare

Additional file 3 of Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

10.6084/m9.figshare.26696136.v1figshare

Related Papers (5)

Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study

N/A

1.3DataRank · unranked

The Lancet(2020)

co-cited

10.1016/s0140-6736(19)32989-7

Extracellular CIRP as an endogenous TREM-1 ligand to fuel inflammation in sepsis

JCI Insight(2020)

co-cited

10.1172/jci.insight.134172

SCHOOL of nature: ligand-independent immunomodulatory peptides

N/A

0.602DataRank · unranked

Drug Discovery Today(2020)

co-cited

10.1016/j.drudis.2020.05.005

The biology of TREM receptors

Nature reviews. Immunology(2023)

co-cited

10.1038/s41577-023-00837-1

Nangibotide for precision immunomodulation in septic shock and COVID-19

The Lancet Respiratory Medicine(2023)

co-cited

10.1016/s2213-2600(23)00220-5